نتایج جستجو برای: hepatic toxicity

تعداد نتایج: 208334  

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010
Suresh S Ramalingam Shivaani Kummar John Sarantopoulos Stephen Shibata Patricia LoRusso Mara Yerk Julianne Holleran Yan Lin Jan H Beumer R Donald Harvey S Percy Ivy Chandra P Belani Merrill J Egorin

PURPOSE Vorinostat is the first US Food and Drug Administration-approved histone deacetylase inhibitor and is indicated for the treatment of refractory cutaneous T-cell lymphoma. We conducted a phase I study to determine the maximum-tolerated dose and pharmacokinetics of vorinostat in patients with hepatic dysfunction. PATIENTS AND METHODS Patients had solid malignancies and acceptable bone m...

Journal: :In vivo 2006
Pier Paolo Cagol Enricomaria Pasqual Stefano Bacchetti

Arterial infusion or perfusion are currently used to treat hepatic tumours, head and neck malignancy, melanomas and sarcomas of the limbs. An experimental study with epirubicin and cis-platinum infused into the hepatic artery was performed. Epirubicin was injected via the systemic vein or the hepatic artery in 27 rats. Cis-platinum was injected via a systemic route or the hepatic artery in 29 r...

Journal: :Molecular cancer therapeutics 2009
Derek G Power Nancy E Kemeny

Liver metastases are mainly supplied by the hepatic artery. Sustained high levels of intratumoral drug are achievable with certain drugs given via the hepatic artery. Floxuridine (FUDR) is an ideal drug for hepatic arterial infusion (HAI) due to its short half life, steep dose response curve, high total body clearance, and high hepatic extraction. HAI FUDR has consistently shown higher response...

20042005200620072008200920102011201220132014201520162017201820192020202120222023050001000015000

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید